SCHEMBL9243246

SCHEMBL9243246

NC(=O)C1C(=O)CCC(=O)C1C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1879279 0.73 CYP2C19 (0.35)
SCHEMBL3944202 0.67 CRBN (0.32)
SCHEMBL775170 0.67 TRIM24 (0.32)
SCHEMBL16058946 0.67
SCHEMBL28645452 0.67
SCHEMBL22020336 0.64
SCHEMBL9700492 0.63 EGLN1 (0.33)
SCHEMBL1148096 0.61 SMN1; SMN2 (0.40)
SCHEMBL21338347 0.61 MEN1 (0.32)
SCHEMBL1743259 0.61 TLR4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0614373-A4 ORAL PHARMACEUTICAL COMPOSITION CONTAINING POLYETHYLENE GLYCOL IMMUNOGLOBULIN CONJUGATE. SINAI SCHOOL MEDICINE (US) 1995-01-18 EP disclosed
EP-0614373-A1 ORAL PHARMACEUTICAL COMPOSITION CONTAINING POLYETHYLENE GLYCOL IMMUNOGLOBULIN CONJUGATE MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK (US) 1994-09-14 EP disclosed
WO-1993008838-A1 ORAL PHARMACEUTICAL COMPOSITION CONTAINING POLYETHYLENE GLYCOL IMMUNOGLOBULIN CONJUGATE MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK (US) 1993-05-13 WO disclosed
US-5169627-A Having resistance to degradation by intestinal enzymes while retaining immunological activity MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK (US) 1992-12-08 US disclosed